![NEOPATHOLOGY CORP Founder and CEO, Paul Aiyetan](/sites/default/files/styles/spotlight_slide/public/spotlight/2024-08/PR%20Spotlight%20neopathology.jpg?itok=-WYQky0S)
TEDCO’s Pre-Seed Rural Business Innovation Initiative Invests in NEOPATHOLOGY CORP.
“Our proprietary approach standardizes the tissue diagnostic process using contemporary spatial biology-enabling platforms,” said Paul Aiyetan, founder, CEO and director of NEOPATHOLOGY CORP. “Through this process, we are hoping to reduce diagnostic errors, improve diagnostic accuracy and expedite the time to treatment initiation. Thanks to TEDCO’s investment, we can continue progressing towards our goals.”